Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Inspire Medical Systems I...

    NYSE: INSP · Real-Time Price · USD
    126.90
    -1.71 (-1.33%)
    At close: Jun 13, 2025, 3:59 PM
    127.25
    0.28%
    After-hours: Jun 13, 2025, 05:22 PM EDT

    Inspire Medical Systems Statistics

    Share Statistics

    Inspire Medical Systems has 29.49M shares outstanding. The number of shares has increased by 0.16% in one year.

    Shares Outstanding

    n/a
    		 29.49M

    Shares Change (YoY)

    n/a
    		 0.16%

    Shares Change (QoQ)

    n/a
    		 -0.69%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 27.62M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,202

    FTD / Avg. Volume

    n/a
    		 0.91%

    Short Selling Information

    The latest short interest is 3.2M, so 10.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.2M

    Short % of Shares Out

    n/a
    		 10.86%

    Short % of Float

    n/a
    		 14.6%

    Short Ratio (days to cover)

    n/a
    		 6.84

    Valuation Ratios

    The PE ratio is 103.11 and the forward PE ratio is 39.82. Inspire Medical Systems's PEG ratio is -0.29.

    PE Ratio

    n/a
    		 103.11

    Forward PE

    n/a
    		 39.82

    PS Ratio

    n/a
    		 6.87

    Forward PS

    n/a
    		 2.2

    PB Ratio

    n/a
    		 8

    P/FCF Ratio

    n/a
    		 60.55

    PEG Ratio

    n/a
    		 -0.29
    Financial Ratio History

    Enterprise Valuation

    Inspire Medical Systems has an Enterprise Value (EV) of 5.4B.

    EV / Sales

    n/a
    		 6.73

    EV / EBITDA

    n/a
    		 83.03

    EV / EBIT

    n/a
    		 41.45

    EV / FCF

    n/a
    		 59.25

    Financial Position

    The company has a current ratio of 7.13, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 7.13

    Quick Ratio

    n/a
    		 6.22

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 0.49

    Debt / FCF

    n/a
    		 0.35

    Interest Coverage

    n/a
    		 1640.14

    Financial Efficiency

    Return on Equity is 7.76% and Return on Invested Capital is 4.59%.

    Return on Equity

    n/a
    		 7.76%

    Return on Assets

    n/a
    		 6.62%

    Return on Invested Capital

    n/a
    		 4.59%

    Revenue Per Employee

    n/a
    		 $644,304.98

    Profits Per Employee

    n/a
    		 $42,944.62

    Employee Count

    n/a
    		 1,246

    Asset Turnover

    n/a
    		 0.99

    Inventory Turnover

    n/a
    		 1.54

    Taxes

    Income Tax

    n/a
    		 4.94M

    Effective Tax Rate

    n/a
    		 8.46%

    Stock Price Statistics

    The stock price has increased by -23.88% in the last 52 weeks. The beta is 1.29, so Inspire Medical Systems's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.29

    52-Week Price Change

    n/a
    		 -23.88%

    50-Day Moving Average

    n/a
    		 147.38

    200-Day Moving Average

    n/a
    		 179.03

    Relative Strength Index (RSI)

    n/a
    		 27.18

    Average Volume (20 Days)

    n/a
    		 570,512

    Income Statement

    In the last 12 months, Inspire Medical Systems had revenue of 802.8M and earned 53.51M in profits. Earnings per share was 1.8.

    Revenue

    n/a
    		 802.8M

    Gross Profit

    n/a
    		 679.82M

    Operating Income

    n/a
    		 36.08M

    Net Income

    n/a
    		 53.51M

    EBITDA

    n/a
    		 65.03M

    EBIT

    n/a
    		 58.48M

    Earnings Per Share (EPS)

    n/a
    		 1.8
    Full Income Statement

    Balance Sheet

    The company has 150.15M in cash and 31.79M in debt, giving a net cash position of 118.36M.

    Cash & Cash Equivalents

    n/a
    		 150.15M

    Total Debt

    n/a
    		 31.79M

    Net Cash

    n/a
    		 118.36M

    Retained Earnings

    n/a
    		 -291.91M

    Total Assets

    n/a
    		 730.81M

    Working Capital

    n/a
    		 508.21M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 130.25M and capital expenditures -39.12M, giving a free cash flow of 91.12M.

    Operating Cash Flow

    n/a
    		 130.25M

    Capital Expenditures

    n/a
    		 -39.12M

    Free Cash Flow

    n/a
    		 91.12M

    FCF Per Share

    n/a
    		 3.06
    Full Cash Flow Statement

    Margins

    Gross margin is 84.68%, with operating and profit margins of 4.49% and 6.67%.

    Gross Margin

    n/a
    		 84.68%

    Operating Margin

    n/a
    		 4.49%

    Pretax Margin

    n/a
    		 7.28%

    Profit Margin

    n/a
    		 6.67%

    EBITDA Margin

    n/a
    		 8.1%

    EBIT Margin

    n/a
    		 4.49%

    FCF Margin

    n/a
    		 11.35%

    Dividends & Yields

    INSP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 0.97%

    FCF Yield

    n/a
    		 1.65%
    Dividend Details

    Analyst Forecast

    The average price target for INSP is $215, which is 69.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $215

    Price Target Difference

    n/a
    		 69.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 11
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 30.62

    Graham Upside

    n/a
    		 -75.87%

    Scores

    Altman Z-Score

    n/a
    		 27.91

    Piotroski F-Score

    n/a
    		 6

    Add to Watchlist